Alterations in proteoglycan synthesis selectively impair FSH-induced particulate cAMP-phosphodiesterase 4 (PDE4) activation in immature rat Sertoli cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 4, 2007, Pages 638-648

  Levallet, Guénaëlle ^a   Levallet, Jérôme ^a   Bonnamy, Pierre Jacques ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

FSH; phosphodiesterase 4D (PDE4D); proteoglycan (PG); rat; Sertoli cell

Indexed keywords

4 NITROPHENYL BETA DEXTRO XYLOSIDE; CARBOHYDRATE DERIVATIVE; CYCLIC AMP; ENZYME VARIANT; FOLLITROPIN; ISOPROTEIN; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV D1; PHOSPHODIESTERASE IV D8; PHOSPHODIESTERASE IV D9; PHOSPHOPROTEIN PHOSPHATASE; PROTEOGLYCAN; SODIUM CHLORATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; HALF LIFE TIME; IMMUNOREACTIVITY; INCUBATION TIME; NONHUMAN; NUCLEOTIDE SEQUENCE; PKA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEOGLYCAN SYNTHESIS; RAT; SERTOLI CELL; UPREGULATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CELLS, CULTURED; CHLORATES; ENZYME ACTIVATION; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSIDES; ISOENZYMES; MALE; PHOSPHODIESTERASE INHIBITORS; PROTEIN BIOSYNTHESIS; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; ROLIPRAM; SERTOLI CELLS; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TIME FACTORS;

RATTUS;

EID: 33847104597     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.12.006     Document Type: Article

References (77)

1. Griswold M.D. The central role of Sertoli cells in spermatogenesis. Semin. Cell Dev. Biol. 9 (1998) 411-416
2. Walker W.H., and Cheng J. FSH and testosterone signaling in Sertoli cells. Reproduction 130 (2005) 15-28
3. Conti M., Toscano M.V., Petrelli L., Geremia R., and Stefanini M. Regulation of follicle-stimulating hormone and dibutyryl adenosine 3′,5′-monophosphate of a phosphodiesterase isoenzyme of the Sertoli cell. Endocrinology 110 (1982) 1189-1196
4. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol. Ther. 109 (2006) 366-398
5. Bender A.T., and Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 58 (2006) 488-520
6. Houslay M.D., and Adams D.R. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370 (2003) 1-18
7. Conti M., Richter W., Mehats C., Livera G., Park J.Y., and Jin C. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J. Biol. Chem. 278 (2003) 5493-5496
8. Richter W., Jin S.L., and Conti M. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue. Biochem. J. (2005)
9. Beard M.B., Olsen A.E., Jones R.E., Erdogan S., Houslay M.D., and Bolger G.B. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions. J. Biol. Chem. 275 (2000) 10349-10358
10. Sette C., and Conti M. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J. Biol. Chem. 271 (1996) 16526-16534
11. Hoffmann R., Wilkinson I.R., McCallum J.F., Engels P., and Houslay M.D. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model. Biochem. J. 333 (1998) 139-149
12. Bolger G.B., Baillie G.S., Li X., Lynch M.J., Herzyk P., Mohamed A., High Mitchell L., McCahill A., Hundsrucker C., Klussmann E., Adams D.R., and Houslay M.D. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem. J. 398 (2006) 23-36
13. Houslay M.D., Sullivan M., and Bolger G.B. The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions. Adv. Pharmacol. 44 (1998) 225-342
14. Baillie G.S., Scott J.D., and Houslay M.D. Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS Lett. 579 (2005) 3264-3270
15. Baillie G.S., and Houslay M.D. Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes. Curr. Opin. Cell Biol. 17 (2005) 129-134
16. Shakur Y., Pryde J.G., and Houslay M.D. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram. Biochem. J. 292 Pt. 3 (1993) 677-686
17. Barnes A.P., Livera G., Huang P., Sun C., O'Neal W.K., Conti M., Stutts M.J., and Milgram S.L. Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium. J. Biol. Chem. 280 (2005) 7997-8003
18. Jin S.L., Bushnik T., Lan L., and Conti M. Subcellular localization of rolipram-sensitive, cAMP-specific phosphodiesterases. Differential targeting and activation of the splicing variants derived from the PDE4D gene. J. Biol. Chem. 273 (1998) 19672-19678
19. McPhee I., Pooley L., Lobban M., Bolger G., and Houslay M.D. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family. Biochem. J. 310 (1995) 965-974
20. Phamantu N.T., Bonnamy P.J., Bouakka M., and Bocquet J. Inhibition of proteoglycan synthesis induces an increase in follicle stimulating hormone (FSH)-stimulated estradiol production by immature rat Sertoli cells. Mol. Cell. Endocrinol. 109 (1995) 37-45
21. Phamantu N.T., Fagnen G., Godard F., Bocquet J., and Bonnamy P.J. Sodium chlorate induces undersulfation of cellular proteoglycans and increases in FSH-stimulated estradiol production in immature rat Sertoli cells. J. Androl. 20 (1999) 241-250
22. Prydz K., and Dalen K.T. Synthesis and sorting of proteoglycans. J. Cell. Sci. 113 Pt. 2 (2000) 193-205
23. Tumova S., Woods A., and Couchman J.R. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int. J. Biochem. Cell Biol. 32 (2000) 269-288
24. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., and Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 (1999) 729-777
25. Carey D.J. Syndecans: multifunctional cell-surface co-receptors. Biochem. J. 327 Pt. 1 (1997) 1-16
26. Simons M., and Horowitz A. Syndecan-4-mediated signalling. Cell Signal. 13 (2001) 855-862
27. Tkachenko E., Rhodes J.M., and Simons M. Syndecans: new kids on the signaling block. Circ. Res. 96 (2005) 488-500
28. Couchman J.R. Syndecans: proteoglycan regulators of cell-surface microdomains?. Nat. Rev., Mol. Cell Biol. 4 (2003) 926-937
29. Carey D.J. Biological functions of proteoglycans: use of specific inhibitors of proteoglycan synthesis. Mol. Cell. Biochem. 104 (1991) 21-28
30. Baeuerle P.A., and Huttner W.B. Chlorate-a potent inhibitor of protein sulfation in intact cells. Biochem. Biophys. Res. Commun. 141 (1986) 870-877
31. Tung P.S., Burdzy K., and Fritz I.B. Proteases are implicated in the changes in the Sertoli cell cytoskeleton elicited by follicle-stimulating hormone or by dibutyryl cyclic AMP. J. Cell. Physiol. 155 (1993) 139-148
32. Galdieri M., and Zani B. Hormonal induced changes in Sertoli cell glycoproteins. Cell Biol. Int. Rep. 5 (1981) 111
33. Chapin R.E., Phelps J.L., Miller B.E., and Gray T.J. Alkaline phosphatase histochemistry discriminates peritubular cells in primary rat testicular cell culture. J. Androl. 8 (1987) 155-161
34. Palombi F., Farini D., Salanova M., de Grossi S., and Stefanini M. Development and cytodifferentiation of peritubular myoid cells in the rat testis. Anat. Rec. 233 (1992) 32-40
35. Skinner M.K., Stallard B., Anthony C.T., and Griswold M.D. Cellular localization of fibronectin gene expression in the seminiferous tubule. Mol. Cell. Endocrinol. 66 (1989) 45-52
36. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
37. Lobban M., Shakur Y., Beattie J., and Houslay M.D. Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: selective localization in membrane and cytosolic compartments and differential expression in various brain regions. Biochem. J. 304 (1994) 399-406
38. Abdolrazaghi Z., and Butterworth P.J. Reactive thiol groups in calf-intestinal alkaline phosphatase. Enzyme 30 (1983) 12-20
39. Kornberg A., and Polliack A. Serum lactic dehydrogenase (LDH) levels in acute leukemia: marked elevations in lymphoblastic leukemia. Blood 56 (1980) 351-355
40. Thompson W.J., and Appleman M.M. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10 (1971) 311-316
41. Wachtel H. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3′, 5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology (Berl) 77 (1982) 309-316
42. Margolis R.K., Goossen B., Tekotte H., Hilgenberg L., and Margolis R.U. Effects of beta-xylosides on proteoglycan biosynthesis and morphology of PC12 pheochromocytoma cells and primary cultures of rat cerebellum. J. Cell. Sci. 99 Pt. 2 (1991) 237-246
43. Swinnen J.V., Tsikalas K.E., and Conti M. Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell. J. Biol. Chem. 266 (1991) 18370-18377
44. Conti M., Iona S., Cuomo M., Swinnen J.V., Odeh J., and Svoboda M.E. Characterization of a hormone-inducible, high affinity adenosine 3′-5′-cyclic monophosphate phosphodiesterase from the rat Sertoli cell. Biochemistry 34 (1995) 7979-7987
45. Morena A.R., Boitani C., de Grossi S., Stefanini M., and Conti M. Stage and cell-specific expression of the adenosine 3′,5′ monophosphate-phosphodiesterase genes in the rat seminiferous epithelium. Endocrinology 136 (1995) 687-695
46. Wang D., Deng C., Bugaj-Gaweda B., Kwan M., Gunwaldsen C., Leonard C., Xin X., Hu Y., Unterbeck A., and De Vivo M. Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7. Cell Signal. 15 (2003) 883-891
47. Bolger G.B., Erdogan S., Jones R.E., Loughney K., Scotland G., Hoffmann R., Wilkinson I., Farrell C., and Houslay M.D. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem. J. 328 (1997) 539-548
48. Salanova M., Chun S.Y., Iona S., Puri C., Stefanini M., and Conti M. Type 4 cyclic adenosine monophosphate-specific phosphodiesterases are expressed in discrete subcellular compartments during rat spermiogenesis. Endocrinology 140 (1999) 2297-2306
49. Fagnen G., Phamantu N.T., Bocquet J., and Bonnamy P.J. Activation of protein kinase C increases proteoglycan synthesis in immature rat Sertoli cells. Biochim. Biophys. Acta 1472 (1999) 250-261
50. De Arcangelis V., Coletti D., Conti M., Lagarde M., Molinaro M., Adamo S., Nemoz G., and Naro F. IGF-I-induced differentiation of L6 myogenic cells requires the activity of cAMP-phosphodiesterase. Mol. Biol. Cell 14 (2003) 1392-1404
51. Liu H., Palmer D., Jimmo S.L., Tilley D.G., Dunkerley H.A., Pang S.C., and Maurice D.H. Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells. J. Biol. Chem. 275 (2000) 26615-26624
52. Bolger G.B., McCahill A., Yarwood S.J., Steele M.S., Warwicker J., and Houslay M.D. Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5, BMC. Biochem 3 (2002) 24
53. Bolger G.B., McCahill A., Huston E., Cheung Y.F., McSorley T., Baillie G.S., and Houslay M.D. The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers preferential interaction with beta-arrestins. J. Biol. Chem. 278 (2003) 49230-49238
54. Resjo S., Oknianska A., Zolnierowicz S., Manganiello V., and Degerman E. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A. Biochem. J. 341 Pt. 3 (1999) 839-845
55. Schonthal A.H. Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett. 170 (2001) 1-13
56. Janssens V., and Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353 (2001) 417-439
57. Sim A.T., Ratcliffe E., Mumby M.C., Villa-Moruzzi E., and Rostas J.A. J Differential activities of protein phosphatase types 1 and 2A in cytosolic and particulate fractions from rat forebrain. Neurochem 62 (1994) 1552-1559
58. Horowitz A., Tkachenko E., and Simons M. Fibroblast growth factor-specific modulation of cellular response by syndecan-4. J. Cell Biol. 157 (2002) 715-725
59. Tasken K., and Aandahl E.M. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev. 84 (2004) 137-167
60. Hayashida K., Johnston D.R., Goldberger O., and Park P.W. Syndecan-1 expression in epithelial cells is induced by TGFbeta through a PKA-dependent pathway. J. Biol. Chem. (2006) 24365-24374
61. Hsueh Y.P., Yang F.C., Kharazia V., Naisbitt S., Cohen A.R., Weinberg R.J., and Sheng M. Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses. J. Cell Biol. 142 (1998) 139-151
62. Cohen A.R., Woods D.F., Marfatia S.M., Walther Z., Chishti A.H., and Anderson J.M. Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J. Cell Biol. 142 (1998) 129-138
63. Konrad L., and Aumuller G. Calcyclin is differentially expressed in rat testicular cells. Biochim. Biophys. Acta 1489 (1999) 440-444
64. Hsueh Y.P. The role of the MAGUK protein CASK in neural development and synaptic function. Curr Med Chem 13 (2006) 1915-1927
65. Caruana G. Genetic studies define MAGUK proteins as regulators of epithelial cell polarity. Int J Dev Biol 46 (2002) 511-518
66. Colledge M., Dean R.A., Scott G.K., Langeberg L.K., Huganir R.L., and Scott J.D. Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex. Neuron 27 (2000) 107-119
67. Morera A.M., Esposito G., Ghiglieri C., Chauvin M.A., Hartmann D.J., and Benahmed M. Transforming growth factor beta 1 inhibits gonadotropin action in cultured porcine Sertoli cells. Endocrinology 130 (1992) 831-836
68. Granes F., Urena J.M., Rocamora N., and Vilaro S. Ezrin links syndecan-2 to the cytoskeleton. J. Cell. Sci. 113 Pt. 7 (2000) 1267-1276
69. Dransfield D.T., Bradford A.J., Smith J., Martin M., Roy C., Mangeat P.H., and Goldenring J.R. Ezrin is a cyclic AMP-dependent protein kinase anchoring protein. EMBO J. 16 (1997) 35-43
70. Miettinen H.M., Edwards S.N., and Jalkanen M. Analysis of transport and targeting of syndecan-1: effect of cytoplasmic tail deletions. Mol. Biol. Cell 5 (1994) 1325-1339
71. Sutherland A.E., Sanderson R.D., Mayes M., Seibert M., Calarco P.G., Bernfield M., and Damsky C.H. Expression of syndecan, a putative low affinity fibroblast growth factor receptor, in the early mouse embryo. Development 113 (1991) 339-351
72. Vannier B., Loosfelt H., Meduri G., Pichon C., and Milgrom E. Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor. Biochemistry 35 (1996) 1358-1366
73. Kato M., Saunders S., Nguyen H., and Bernfield M. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. Biol. Cell 6 (1995) 559-576
74. Leppa S., Mali M., Miettinen H.M., and Jalkanen M. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 932-936
75. Inki P., and Jalkanen M. The role of syndecan-1 in malignancies. Ann. Med. 28 (1996) 63-67
76. Steinberger A., Hintz M., and Heindel J.J. Changes in cyclic AMP responses to FSH in isolated rat Sertoli cells during sexual maturation. Biol. Reprod. 19 (1978) 566-572
77. Heindel J.J., Hintz M.I., Steinberger E., and Strada S.J. Effects of FSH on cyclic nucleotide accumulation in testes of rats of various ages. Endocr. Res. Commun. 4 (1977) 311-328